tiprankstipranks
10x Genomics reports Q1 EPS (44c), consensus (37c)
The Fly

10x Genomics reports Q1 EPS (44c), consensus (37c)

Reports Q1 revenue $134.3M, consensus $128.82M. "We are proud of our solid start to the year, fueled by strong performance across our spatial portfolio and a return to double-digit growth in single cell consumables," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "We are energized by the momentum and traction we’re seeing with Xenium in its first full quarter of launch; the overwhelmingly positive feedback from our early customers reinforces our belief that Xenium is the best In Situ platform on the market."

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on TXG:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles